C4 Therapeutics to Participate in Upcoming March Conferences

On February 23, 2026 C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, reported that C4T management will participate in two upcoming March conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 46th Annual Healthcare Conference:
Management will present and participate in a fireside chat on March 3, 2026, at 11:50 AM ET taking place in Boston, Massachusetts.
Barclays 28th Annual Global Healthcare Conference:
Management will participate in a fireside chat on March 10, 2026 at 8:00 AM ET taking place in Miami, Florida.
The live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com. The archived replays of the webcasts will be available for approximately 90 days following the events.

(Press release, C4 Therapeutics, FEB 23, 2026, View Source [SID1234662848])